Dilan Athauda, PhD - Neurodegeneration Biology Laboratory, Francis Crick Institute, London, United Kingdom, UCL Queen Square Institute of Neurology, London, United Kingdom, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom

James Evans, MSc - Neurodegeneration Biology Laboratory, Francis Crick Institute, London, United Kingdom, UCL Queen Square Institute of Neurology, London, United Kingdom

Anna Wernick, MSc - Neurodegeneration Biology Laboratory, Francis Crick Institute, London, United Kingdom, UCL Queen Square Institute of Neurology, London, United Kingdom

Gurvir Virdi, MSc - Neurodegeneration Biology Laboratory, Francis Crick Institute, London, United Kingdom, UCL Queen Square Institute of Neurology, London, United Kingdom

Minee L. Choi, PhD - Neurodegeneration Biology Laboratory, Francis Crick Institute, London, United Kingdom, UCL Queen Square Institute of Neurology, London, United Kingdom

Michael Lawton, PhD - School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

Nirosen Vijiaratnam, MRCP - Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom

Christine Girges, PhD - Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom

Yoav Ben-Shlomo, PhD - School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

Khalida Ismail, PhD - Department of Psychological Medicine, King’s College London, United Kingdom

Huw Morris, PhD - Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom

Donald Grosset, PhD - Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom

Thomas Foltynie, PhD - Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom

Sonia Gandhi, PhD - Neurodegeneration Biology Laboratory, Francis Crick Institute, London, United Kingdom, UCL Queen Square Institute of Neurology, London, United Kingdom, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom

Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.

Upon completion of this activity learners will be able to:

1. Evaluate the influence of T2DM on aspects of disease progression in Parkinson’s disease
2. Assess the motor and nonmotor outcomes that were selected for the study to highlight the influence of T2DM on PD
3. Understand how T2DM can be an independent risk factor associated with more severe motor symptoms, nonmotor symptoms, and poorer quality-of-life scores in patients recently diagnosed with PD

This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

Vikas Kotagal: Course Director

Nothing to Disclose

Veronica Santini: Reviewer

Grant: Insightec, Biogen, Roche / Genentech

Dilan Athauda: Author

Honoraria: Bial Pharma

James Evans: Author

Nothing to Disclose

Anna Wernick: Author

Nothing to Disclose

Gurvir Virdi: Author

Nothing to Disclose

Minee L. Choi: Author

Nothing to Disclose

Michael Lawton: Author

Nothing to Disclose

Nirosen Vijiaratnam: Author

Grant: IPSEN, Biogen, AbbVie; Honoraria: AbbVie, STADA; Advisory Board: AbbVie, Brittania

Christine Girges: Author

Nothing to Disclose

Yoav Ben-Shlomo: Author

Nothing to Disclose

Khalida Ismail: Author

Nothing to Disclose

Huw Morris: Author

Consultant: Biogen, UCB, AbbVie, Denali, Biohaven, Lundbeck; Honoraria: Biogen, UCB, C4X Discovery, GE-Healthcare

Donald Grosset: Author

Honoraria: Bial Pharma, Merz Pharma

Thomas Foltynie: Author

Honoraria: Profile Pharma, BIAL, AbbVie, Genus, Medtronic

Sonia Gandhi: Author
Nothing to Disclose

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.

2. Compatible with Windows PC and MAC (256 MB of RAM or higher)

3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher

4. Adobe Flash Player 12.0 (or higher).

5. Adobe Reader to print certificate.

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.